OWC Pharmaceutical Research Corp. (OWCP), (“OWC” or the “Company”), an Israeli-based developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today announced it signed an agreement for $300,000 with Medmar LLC (“Medmar”).

According to the terms of the agreement:

The funds will be allocated to complete the development of the Company’s proprietary psoriasis cream;

Medmar will have exclusive right to manufacture, produce, publicize, promote and market OWC’s Licensed Products in any state in the U.S;

The loan is non-interest bearing and will be repaid from royalties generated by the sale of OWC licensed products.

Commenting on his investment, Steve Weinstein, CEO of Medmar said, “Medmar has been anxious to advance cannabis as medicine, however US regulation makes it very difficult for companies here to actively pursue any type of development in the sector; fortunately, the environment in Israel is more favorable to the industry.”

Mr. Weinstein went on to say, “We learned about OWC as they are one of only a handful of companies taking a true clinical approach to the research and development of medical cannabis, and this was important to us. Once we saw the preliminary results for their clinical studies, particularly in the field of psoriasis, we decided to make an investment and partner with them.”

Mordechai Bignitz, OWC’s Chairman and CEO, also commented on the announcement, “As we continue to make progress in our clinical trials for multiple myeloma, psoriasis and fibromyalgia, we are excited to partner with MedMar as we prepare to bring products to market. Their confidence in the potential for the commercialization of our research is clearly evident in the terms of this agreement.”

About OWC Pharmaceutical Research Corp.

OWC Pharmaceutical Research Corp., through its wholly-owned Israeli subsidiary, One Word Cannabis Ltd., (collectively “OWC” or the “Company”) conducts medical research and clinical trials to develop cannabis-based pharmaceuticals and treatments for conditions including multiple myeloma, psoriasis, fibromyalgia, PTSD, and migraines. OWC is also developing unique delivery systems for the effective delivery and dosage of medical cannabis. All OWC research is conducted at leading Israeli hospitals and scientific institutions, and led by internationally renowned investigators.

The Company’s Research Division is focused on pursuing clinical trials evaluating the effectiveness of cannabinoids for the treatment of various medical conditions, while its Consulting Division is dedicated to helping governments and companies navigate complex international cannabis regulatory frameworks. For more information, visit: http://www.owcpharma.com/

The average daily trading volume (ADTV) is the number of commodities traded per day on average over a specific time period. Trading activity is tied to the liquidity of a stock. If there is high average daily trading volume, the security can be moved easily and has high liquidity. In contrast, if trading volume is low, the commodity will usually be less expensive due to the fact that people are not as eager to buy Terra Tech, Corp. (OTCMKTS:TRTC)’s average trading volume is 105100.

Are OWC Pharmaceutical Research, Corp. (OTCMKTS:OWCP) Shares Ready to Explode? Sign up to our Newsletter to be the First to Know

Sign up to get our Free Penny Stock Picks Before the Street!

OWC Pharmaceutical Research, Corp. (OTCMKTS:OWCP) shares closed the most recent session at $0.017, moving from the previous open of $0.0062. This is compared to the stock’s 52-week high of 0.15 and 52-week low of N/A.

It’s important to use market capitalization (market cap) to show the size of a company because company size is a basic characteristic in which investors are interested. Luckily, it’s easy to calculate: Market Capitalization = Number of Shares Outstanding x Price. For example, if a company has 10 million shares selling at $100/share, it would have a market cap of $1 billion. Currently, OWC Pharmaceutical Research, Corp. (OTCMKTS:OWCP)s market cap is $2230000.

Sign Up to Receive Breaking Alerts on Stocks That Are Primed to Make a Run in the Bar Below.

Sign up to get our Free Penny Stock Picks Before the Street!

Disclaimer: The views, opinions, and information expressed in this article are those of the authors and do not necessarily reflect the official policy or position of any company stakeholders, financial professionals, or analysts. Examples of analysis performed within this article are only examples. They should not be utilized to make stock portfolio or financial decisions as they are based only on limited and open source information. Assumptions made within the analysis are not reflective of the position of any analysts or financial professionals.